Literature DB >> 28797581

Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells.

Inge M N Wortel1, Laurens T van der Meer2, Michael S Kilberg3, Frank N van Leeuwen4.   

Abstract

Activating transcription factor 4 (ATF4) is a stress-induced transcription factor that is frequently upregulated in cancer cells. ATF4 controls the expression of a wide range of adaptive genes that allow cells to endure periods of stress, such as hypoxia or amino acid limitation. However, under persistent stress conditions, ATF4 promotes the induction of apoptosis. Recent advances point to a role for post-translational modifications (PTMs) and epigenetic mechanisms in balancing these pro- and anti-survival effects of ATF4. We review here how PTMs and epigenetic modifiers associated with ATF4 may be exploited by cancer cells to cope with cellular stress conditions that are intrinsically associated with tumor growth. Identification of mechanisms that modulate ATF4-mediated transcription and its effects on cellular metabolism may uncover new targets for cancer treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATF4; cellular stress; post-translational modification

Mesh:

Substances:

Year:  2017        PMID: 28797581      PMCID: PMC5951684          DOI: 10.1016/j.tem.2017.07.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  112 in total

1.  Stress-induced gene expression requires programmed recovery from translational repression.

Authors:  Isabel Novoa; Yuhong Zhang; Huiqing Zeng; Rivka Jungreis; Heather P Harding; David Ron
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

Review 2.  Cell death by autophagy: facts and apparent artefacts.

Authors:  D Denton; S Nicolson; S Kumar
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

3.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

4.  p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain.

Authors:  Irina Lassot; Emilie Estrabaud; Stephane Emiliani; Monsef Benkirane; Richard Benarous; Florence Margottin-Goguet
Journal:  J Biol Chem       Date:  2005-10-11       Impact factor: 5.157

Review 5.  Mediators of endoplasmic reticulum stress-induced apoptosis.

Authors:  Eva Szegezdi; Susan E Logue; Adrienne M Gorman; Afshin Samali
Journal:  EMBO Rep       Date:  2006-09       Impact factor: 8.807

6.  Up-Regulated ATF4 Expression Increases Cell Sensitivity to Apoptosis in Response to Radiation.

Authors:  Ying Zong; Shijie Feng; Jinwei Cheng; Chenlin Yu; Guocai Lu
Journal:  Cell Physiol Biochem       Date:  2017-02-13

7.  ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.

Authors:  Meixia Bi; Christine Naczki; Marianne Koritzinsky; Diane Fels; Jaime Blais; Nianping Hu; Heather Harding; Isabelle Novoa; Mahesh Varia; James Raleigh; Donalyn Scheuner; Randal J Kaufman; John Bell; David Ron; Bradly G Wouters; Constantinos Koumenis
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

9.  Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.

Authors:  Shalini Jain; Goutam Chakraborty; Remya Raja; Smita Kale; Gopal C Kundu
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 10.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28
View more
  118 in total

1.  Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Cole D Davidson; Princess D Rodriguez; Lauren Cozzens; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Mol Cancer Res       Date:  2020-06-17       Impact factor: 5.852

2.  Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.

Authors:  Xufeng Chen; Christina Glytsou; Hua Zhou; Sonali Narang; Denis E Reyna; Andrea Lopez; Theodore Sakellaropoulos; Yixiao Gong; Andreas Kloetgen; Yoon Sing Yap; Eric Wang; Evripidis Gavathiotis; Aristotelis Tsirigos; Raoul Tibes; Iannis Aifantis
Journal:  Cancer Discov       Date:  2019-05-02       Impact factor: 39.397

3.  TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation.

Authors:  Erin M O'Leary; Yufeng Tian; Recep Nigdelioglu; Leah J Witt; Rengul Cetin-Atalay; Angelo Y Meliton; Parker S Woods; Lucas M Kimmig; Kaitlyn A Sun; Gizem A Gökalp; Gökhan M Mutlu; Robert B Hamanaka
Journal:  Am J Respir Cell Mol Biol       Date:  2020-11       Impact factor: 6.914

Review 4.  Role of the mitochondrial stress response in human cancer progression.

Authors:  Sheng-Fan Wang; Shiuan Chen; Ling-Ming Tseng; Hsin-Chen Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

5.  The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis.

Authors:  Xin Jin; Jianling Xie; Michael Zabolocki; Xuemin Wang; Tao Jiang; Dong Wang; Laurent Désaubry; Cedric Bardy; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-05-19       Impact factor: 5.157

6.  RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.

Authors:  Jaebeom Cho; Hye-Young Min; Ho Jin Lee; Seung Yeob Hyun; Jeong Yeon Sim; Myungkyung Noh; Su Jung Hwang; Shin-Hyung Park; Hye-Jin Boo; Hyo-Jong Lee; Sungyoul Hong; Rang-Woon Park; Young Kee Shin; Mien-Chie Hung; Ho-Young Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

7.  Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer.

Authors:  Nora Pällmann; Marte Livgård; Martina Tesikova; Hatice Zeynep Nenseth; Erman Akkus; Jørgen Sikkeland; Yixin Jin; Dogukan Koc; Omer Faruk Kuzu; Manohar Pradhan; Håvard E Danielsen; Nermin Kahraman; Hamada M Mokhlis; Bulent Ozpolat; Partha P Banerjee; Aykut Uren; Ladan Fazli; Paul S Rennie; Yang Jin; Fahri Saatcioglu
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

8.  ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-Asparaginase.

Authors:  Robert T Williams; Rohiverth Guarecuco; Leah A Gates; Douglas Barrows; Maria C Passarelli; Bryce Carey; Lou Baudrier; Swarna Jeewajee; Konnor La; Benjamin Prizer; Sohail Malik; Javier Garcia-Bermudez; Xiphias Ge Zhu; Jason Cantor; Henrik Molina; Thomas Carroll; Robert G Roeder; Omar Abdel-Wahab; C David Allis; Kıvanç Birsoy
Journal:  Cell Metab       Date:  2020-04-07       Impact factor: 27.287

9.  Stress-induced changes in CARF expression determine cell fate to death, survival, or malignant transformation.

Authors:  Rajkumar S Kalra; Anupama Chaudhary; Amr Omar; Caroline T Cheung; Sukant Garg; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2020-03-27       Impact factor: 3.667

10.  EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC.

Authors:  Gnana P Krishnamoorthy; Natalie R Davidson; Steven D Leach; Zhen Zhao; Scott W Lowe; Gina Lee; Iňigo Landa; James Nagarajah; Mahesh Saqcena; Kamini Singh; Hans-Guido Wendel; Snjezana Dogan; Prasanna P Tamarapu; John Blenis; Ronald A Ghossein; Jeffrey A Knauf; Gunnar Rätsch; James A Fagin
Journal:  Cancer Discov       Date:  2018-10-10       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.